TY  - GEN 
AU  - Sancho, Juan-Manuel
AU  - Marín‑Niebla, Ana
AU  - Fernández, Silvia
AU  - Capote Huelva, Francisco Javier
AU  - Cañigral, Carolina
AU  - Grande, Carlos
AU  - Donato, Eva
AU  - Zeberio, Izaskun
AU  - Puerta, Jose-Manuel
AU  - Rivas, Alfredo
AU  - Pérez‑Ceballos, Elena
AU  - Vale, Ana
AU  - García‑Sancho, Alejandro Martín
AU  - Salar, Antonio
AU  - González‑Barca, Eva
AU  - Teruel, Anabel
AU  - Pastoriza, Carmen
AU  - Conde‑Royo, Diego
AU  - Sánchez‑García, Joaquín
AU  - Barrenetxea, Cristina
AU  - Arranz, Reyes
AU  - Hernández‑Rivas, Jose-Angel
AU  - Ramírez, María‑José
AU  - Jiménez, Aroa
AU  - Rubio‑Azpeitia, Eva
A4  - Medicina
PY  - 2022
SN  - 1865-3774
UR  - http://hdl.handle.net/10498/27140
AB  - This retrospective study evaluated 66 patients diagnosed with relapsed and/or refractory mantle cell lymphoma (R/R MCL)
treated with ibrutinib in Spain in routine clinical practice. At diagnosis, patients had a median age of 64.5 years, 63.6%...
LA  - eng
PB  - SPRINGER
KW  - Mantle-cell lymphoma
KW  - Relapsed/refractory
KW  - Ibrutinib
KW  - Clinical practice
KW  - Real-world evidence
TI  - IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice
DO  - 10.1007/S12185-022-03367-Z
ER  -